@FierceMedDev: Micro-cap TearLab gets $35M in debt to get to breakeven on dry eye test . More | Follow @FierceMedDev
@VarunSaxena2: @AdvaMedUpdate calls for more appropriate medical device reimbursement in Japan - FierceMedicalDevices. Story | Follow @VarunSaxena2
@EmilyWFierce: OpGen eyes IPO worth up to $37M for drug-resistant bacteria genetic Dx. FierceDiagnostics article | Follow @EmilyWFierce
> Linden Capital Partners has closed an oversubscribed $750 million fund to invest in mid-market healthcare and life sciences companies. More
> Chicago-based healthcare incubator Matter added 10 more startups including Briteseed, which integrates biosensors into minimally invasive surgical tools; surgeon-backed device and app developer Jacobson Medical Services; and Pathfinder Software, which develops software to connect medical devices and wearable sensors with mobile, cloud computing and clinical systems. Blog
> Johnson & Johnson's ($JNJ) Alcon Laboratories and other contact lens manufacturers are targeted in a class action lawsuit in a California court that they illegally controlled prices on contact lenses sold at Wal-Mart ($WMT) and other major retailers. More (reg. req.)
> A new wearable from startup Skulpt measures the quality of muscle fibers and the amount of fat on a person's body. Story
Biotech News
@FierceBiotech: Biotech upstart Tricida banks $30M for its kidney drug with OrbiMed in tow. Story | Follow @FierceBiotech
@JohnCFierce: Interested in Asian biopharma? Get the latest from @FiercePharmAsia. Newsletter | Follow @JohnCFierce
@DamianFierce: Via @Reuters, it's March 5 and biopharma deal dollars have already topped 2011. Article | Follow @DamianFierce
> Surprised, stunned and supportive: Analysts assess AbbVie's $21B Pharmacyclics deal. Editor's Corner
> Summit pulls off a downsized IPO for its DMD drug. Story
Pharma News
@FiercePharma: #ICYMI yesterday: $BMY leapfrogs Merck with Opdivo approval in lung cancer. Story | Follow @FiercePharma
@EricPFierce: MS Pharma in Jordan gets $30M development loan to expand its drug manufacturing. News | Follow @EricPFierce
@CarlyHFierce: J&J, Merck to advance #Ebola vaccines in Africa, but their fate rests in WHO's hands. More | Follow @CarlyHFierce
> Mallinckrodt ponies up $2.3B for Ikaria and its neonatal respiratory med. Article
> Oregon, Illinois join state crusade to limit patient copays. Story
Pharma Asia News
> Major policy shift on costs and safety views as China moves to lift price controls on drugs. News
> Denovo Biopharma eyes China trial of licensed Eli Lilly neuroscience drug. Article
> Indonesia gains momentum as drug firms eye second year of phased national insurance. Item
> Big Pharma bodies ask China FDA to review comparability in biosimilar approval guidelines. More
> Hutchison China MediTech eyes first modern drug approval in China next year with Eli Lilly candidate. Report
Vaccines News
> Pfizer scores new Prevenar indication in Europe. Article
> Bristol-Myers bets $1B on Bavarian Nordic cancer vaccine. News
> J&J, Merck to advance Ebola vaccines in Africa, but their fate rests in WHO's hands. Story
> With 77 layoffs, Valeant gets to work squeezing costs from Dendreon. Item
> Aduro, BMS cancer vaccine combo to start Phase II. Report
Pharma Manufacturing News
> FDA aims to disseminate drug shortage info through app. More
> Generic drugmaker snaps up Lockheed site with big expansion plans. Article
> Jordan's MS Pharma gets $30M to expand manufacturing there. Report
> FDA campaign against use of foreign-made cancer drugs rolls up another doctor. Story
> Patheon buys specialty API maker IRIX. News
And Finally... CSL Plasma will use the Haemonetics ($HAE) software to manage plasma collection at its more than 100 plasma donation centers across the U.S. and Europe. Release